Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

McKinsey
Harvard Business School
Baxter
Colorcon
AstraZeneca
Express Scripts

Last Updated: December 5, 2019

DrugPatentWatch Database Preview

Protamine sulfate - Generic Drug Details

See Plans and Pricing

« Back to Dashboard

Summary for protamine sulfate
Recent Clinical Trials for protamine sulfate

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Fayoum University HospitalN/A
Fayoum UniversityPhase 4
Ain Shams UniversityEarly Phase 1

See all protamine sulfate clinical trials

Pharmacology for protamine sulfate

US Patents and Regulatory Information for protamine sulfate

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
West-ward Pharms Int PROTAMINE SULFATE protamine sulfate INJECTABLE;INJECTION 089475-001 Nov 5, 1986 DISCN No No   Start Trial   Start Trial   Start Trial
Pharmacia And Upjohn PROTAMINE SULFATE protamine sulfate INJECTABLE;INJECTION 007413-002 Aug 2, 1984 DISCN No No   Start Trial   Start Trial   Start Trial
Lilly PROTAMINE SULFATE protamine sulfate INJECTABLE;INJECTION 006460-002 Approved Prior to Jan 1, 1982 DISCN Yes No   Start Trial   Start Trial   Start Trial
West-ward Pharms Int PROTAMINE SULFATE protamine sulfate INJECTABLE;INJECTION 089474-001 Nov 5, 1986 DISCN No No   Start Trial   Start Trial   Start Trial
Pharmacia And Upjohn PROTAMINE SULFATE protamine sulfate INJECTABLE;INJECTION 007413-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Fresenius Kabi Usa PROTAMINE SULFATE protamine sulfate INJECTABLE;INJECTION 089454-001 Apr 7, 1987 RX No Yes   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Johnson and Johnson
McKesson
Harvard Business School
Medtronic
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.